HSBC Holdings’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.64M | Sell |
40,800
-53,300
| -57% | -$7.46M | ﹤0.01% | 1135 |
|
|
2025
Q4 | $11.6M | Buy |
94,100
+7,400
| +9% | +$899K | 0.01% | 903 |
|
|
2025
Q3 | $9.83M | Buy |
86,700
+37,800
| +77% | +$4.3M | 0.01% | 930 |
|
|
2025
Q2 | $5.41M | Sell |
48,900
-73,100
| -60% | -$7.78M | ﹤0.01% | 1128 |
|
|
2025
Q1 | $13.5M | Buy |
122,000
+36,700
| +43% | +$3.79M | 0.01% | 813 |
|
|
2024
Q4 | $7.86M | Hold |
85,300
| – | – | ﹤0.01% | 1005 |
|
|
2024
Q3 | $7.12M | Sell |
85,300
-45,000
| -35% | -$3.43M | ﹤0.01% | 1000 |
|
|
2024
Q2 | $8.96M | Sell |
130,300
-8,500
| -6% | -$567K | 0.01% | 897 |
|
|
2024
Q1 | $10.2M | Buy |
138,800
+8,300
| +6% | +$638K | 0.01% | 874 |
|
|
2023
Q4 | $10.6M | Buy |
130,500
+57,600
| +79% | +$4.48M | 0.01% | 873 |
|
|
2023
Q3 | $5.47M | Buy |
72,900
+19,200
| +36% | +$1.48M | 0.01% | 1049 |
|
|
2023
Q2 | $4.12M | Sell |
53,700
-184,400
| -77% | -$14.7M | ﹤0.01% | 1130 |
|
|
2023
Q1 | $19.5M | Buy |
238,100
+28,500
| +14% | +$2.36M | 0.02% | 618 |
|
|
2022
Q4 | $17.8M | Sell |
209,600
-13,800
| -6% | -$1.09M | 0.02% | 697 |
|
|
2022
Q3 | $13.9M | Buy |
223,400
+37,500
| +20% | +$2.36M | 0.02% | 694 |
|
|
2022
Q2 | $11.6M | Buy |
185,900
+114,900
| +162% | +$7.11M | 0.02% | 813 |
|
|
2022
Q1 | $4.22M | Buy |
71,000
+22,500
| +46% | +$1.44M | 0.01% | 1247 |
|
|
2021
Q4 | $3.52M | Buy |
48,500
+19,000
| +64% | +$1.31M | ﹤0.01% | 1433 |
|
|
2021
Q3 | $2.06M | Hold |
29,500
| – | – | ﹤0.01% | 1519 |
|
|
2021
Q2 | $2.03M | Buy |
29,500
+29,300
| +14,650% | +$1.96M | ﹤0.01% | 1438 |
|
|
2021
Q1 | $13K | Sell |
200
-13,800
| -99% | -$890K | ﹤0.01% | 2685 |
|
|
2020
Q4 | $816K | Sell |
14,000
-5,000
| -26% | -$302K | ﹤0.01% | 1841 |
|
|
2020
Q3 | $1.2M | Sell |
19,000
-139,800
| -88% | -$9.69M | ﹤0.01% | 1466 |
|
|
2020
Q2 | $12.2M | Buy |
158,800
+136,800
| +622% | +$10.5M | 0.02% | 581 |
|
|
2020
Q1 | $1.65M | Sell |
22,000
-113,100
| -84% | -$7.82M | ﹤0.01% | 1258 |
|
|
2019
Q4 | $8.77M | Sell |
135,100
-298,100
| -69% | -$19.4M | 0.02% | 870 |
|
|
2019
Q3 | $27.5M | Buy |
433,200
+215,000
| +99% | +$14.1M | 0.05% | 411 |
|
|
2019
Q2 | $14.7M | Sell |
218,200
-145,200
| -40% | -$9.55M | 0.03% | 640 |
|
|
2019
Q1 | $23.6M | Sell |
363,400
-126,800
| -26% | -$8.43M | 0.04% | 451 |
|
|
2018
Q4 | $30.7M | Sell |
490,200
-28,500
| -5% | -$1.99M | 0.06% | 347 |
|
|
2018
Q3 | $40M | Sell |
518,700
-257,500
| -33% | -$19.4M | 0.06% | 301 |
|
|
2018
Q2 | $55M | Buy |
776,200
+375,100
| +94% | +$26.5M | 0.1% | 178 |
|
|
2018
Q1 | $30.2M | Buy |
401,100
+400,900
| +200,450% | +$31.9M | 0.05% | 392 |
|
|
2017
Q4 | $14K | Sell |
200
-565,600
| -100% | -$43M | ﹤0.01% | 2011 |
|
|
2017
Q3 | $45.8M | Buy |
565,800
+202,800
| +56% | +$15.5M | 0.07% | 253 |
|
|
2017
Q2 | $25.7M | Sell |
363,000
-48,100
| -12% | -$3.2M | 0.05% | 432 |
|
|
2017
Q1 | $27.9M | Buy |
411,100
+43,100
| +12% | +$3.03M | 0.06% | 360 |
|
|
2016
Q4 | $26.4M | Buy |
368,000
+126,900
| +53% | +$9.43M | 0.06% | 382 |
|
|
2016
Q3 | $19.1M | Sell |
241,100
-65,800
| -21% | -$5.35M | 0.05% | 452 |
|
|
2016
Q2 | $25.6M | Sell |
306,900
-60,600
| -16% | -$5.38M | 0.07% | 334 |
|
|
2016
Q1 | $33.8M | Sell |
367,500
-72,600
| -16% | -$6.55M | 0.1% | 246 |
|
|
2015
Q4 | $44.5M | Buy |
440,100
+399,500
| +984% | +$41.6M | 0.11% | 213 |
|
|
2015
Q3 | $3.99M | Buy |
40,600
+28,560
| +237% | +$3.17M | 0.01% | 878 |
|
|
2015
Q2 | $1.41M | Sell |
12,040
-343,360
| -97% | -$37.5M | ﹤0.01% | 1167 |
|
|
2015
Q1 | $34.9M | Sell |
355,400
-8,800
| -2% | -$894K | 0.07% | 300 |
|
|
2014
Q4 | $34.3M | Buy |
364,200
+83,900
| +30% | +$8.68M | 0.07% | 291 |
|
|
2014
Q3 | $29.8M | Buy |
280,300
+190,900
| +214% | +$18.7M | 0.06% | 314 |
|
|
2014
Q2 | $7.41M | Buy |
89,400
+56,400
| +171% | +$4.39M | 0.02% | 715 |
|
|
2014
Q1 | $2.34M | Sell |
33,000
-67,000
| -67% | -$5.25M | 0.01% | 1022 |
|
|
2013
Q4 | $7.51M | Hold |
100,000
| – | – | 0.02% | 724 |
|
|
2013
Q3 | $6.29M | Buy |
100,000
+99,000
| +9,900% | +$5.92M | 0.02% | 764 |
|
|
2013
Q2 | $51K | Buy |
+1,000
| New | +$52.1K | ﹤0.01% | 1513 |
|
Other funds holding GILD
VCM
VPM
HSBC Holdings's GILD Position: Q1 2026 in Review
HSBC Holdings reduced its Gilead Sciences (GILD) stake by 15% in Q1 2026, selling an estimated $81.9M and leaving 3,190,339 shares worth $444M. The position accounts for 0.23% of the portfolio, ranked #76.
HSBC Holdings first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $464M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- HSBC Holdings held 3,190,339 shares of Gilead Sciences worth $444M as of Q1 2026.
- HSBC Holdings sold 584,817 Gilead Sciences shares in Q1 2026, an estimated $81.9M.
- Gilead Sciences made up 0.23% of HSBC Holdings's portfolio in Q1 2026, its #76 holding.
- HSBC Holdings first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- HSBC Holdings's Gilead Sciences position peaked at $464M in Q4 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.